Theravance Biopharma Inc (NASDAQ:TBPH)

21.73
Delayed Data
As of Feb 27
 +0.84 / +4.02%
Today’s Change
13.11
Today|||52-Week Range
35.67
+45.64%
Year-to-Date

Today’s Trading

Previous close20.89
Today’s open20.93
Day’s range20.80 - 22.00
Volume168,006
Average volume (3 months)286,388
Market cap$700.3M
Dividend yield--
Data as of 3:59pm ET, 02/27/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-99.83%
P/E ratio--
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
OREXOrexigen Therapeutic...-0.23-3.92%
SCMPSucampo Pharmaceutic...-0.62-3.87%
PRTAProthena Corporation...-0.94-3.42%
ITCIIntra-Cellular Thera...-1.14-4.39%
Data as of 3:59pm ET, 02/27/2015

Financials

Next reporting dateMarch 2, 2015
EPS forecast (this quarter)-$1.62
Annual revenue (last year)$226.0K
Annual profit (last year)-$156.3M
Net profit margin-69,152.21%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Rick E. Winningham
Senior Vice President-
Operations
Frank C. Pasqualone
Corporate headquarters
George Town, George Town

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account